For instance, among these 13 features uniquely enriched by DeePaN, features relevant to peripheral immune status such as high blood monocyte count and low blood lymphocyte count are associated with poor post-IO prognosis in NSCLC with supporting literatures48–50; KRAS mutations are enriched with the IO-beneficial subgroup51. This evidence concerns the gene KRAS and non-small cell lung carcinoma.